Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Invasive Fungal Infections Market From 2025 To 2034?
The invasive fungal infections market has demonstrated steady growth in recent years. It is anticipated to increase from $7.58 billion in 2024 to $7.91 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.3%. The expansion observed in previous periods is attributable to factors such as the global spread of infections, hematopoietic stem cell transplants, an aging population, hospital-acquired infections, and various environmental factors.
The invasive fungal infections market size is expected to show sustained growth in the coming years, reaching “$9.5 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%.” This expansion in the forecast period is attributable to global health preparedness, public health education initiatives, the development of novel antifungal agents, the effects of climate change, and multidisciplinary approaches. Significant trends during the forecast period include progress in diagnostic technologies, the adoption of tailored therapeutic approaches, an emphasis on patient-centric care, the use of combination antifungal therapies, and enhanced collaborations for drug development.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13189&type=smp
Which Major Market Drivers Are Shaping The Future Of The Invasive Fungal Infections Market?
The invasive fungal infection market is projected to expand due to the increasing population suffering from human immunodeficiency virus (HIV). HIV, or Human Immunodeficiency Virus infection, is a virus that compromises the immune system’s ability to protect against diseases and illnesses. A growing number of individuals with compromised immune systems, like those with HIV or AIDS (acquired immunodeficiency syndrome), are more susceptible to invasive fungal infections. This creates avenues for manufacturers to innovate and supply specialized and more effective antifungal drugs. For instance, in July 2023, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-based United Nations program dedicated to tackling the global HIV/AIDS epidemic, the worldwide population living with HIV rose to 39 million in 2022, an increase of 3.17% from 37.7 million in 2020. Furthermore, roughly 1.3 million new HIV infections were reported in 2022. Consequently, the rising population affected by human immunodeficiency virus (HIV) will stimulate the growth of the invasive fungal infection market.
What Are The Major Segments Identified In The Invasive Fungal Infections Market?
The invasive fungal infectionsmarket covered in this report is segmented –
1) By Disease Type: Candidemia And Invasive Candidiasis; Intra Abdominal Candidiasis; Cryptococcal Meningitis; Esophageal Candidiasis; Histoplasmosis Acute Pulmonary; Other Disease Type
2) By Drug Type: Polyenes; Triazoles; Echinocandins; Flucytosine; Other Drug Type
3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Candidemia And Invasive Candidiasis: Bloodstream Infections; Disseminated Candidiasis
2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis; Abscess Formation
3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis; Secondary Cryptococcal Meningitis
4) By Esophageal Candidiasis: Acute Esophageal Candidiasis; Chronic Esophageal Candidiasis
5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis; Chronic Pulmonary Histoplasmosis
6) By Other Disease Types: Aspergillosis; Mucormycosis; Other Rare Fungal Infections
What Are The Latest Industry Trends Transforming The Invasive Fungal Infections Market?
Leading companies in the invasive fungal infection market are concentrating on advanced products like Zisavel capsules to improve treatment effectiveness, achieve better patient results, and broaden availability for individuals suffering from severe fungal infections. Zisavel capsules are a generic antifungal medicine derived from isavuconazole, developed to treat invasive aspergillosis and mucormycosis. These 100 mg capsules aim to offer an affordable alternative for patients, thereby increasing access to effective treatment. As an illustration, in October 2023, BDR Pharmaceuticals, an India-based generic and specialty pharmaceutical company, launched a generic antifungal drug, Zisavel Capsules, for addressing invasive aspergillosis and mucormycosis. Zisavel is indicated for the treatment of invasive aspergillosis and mucormycosis, both considered severe fungal infections that can be life-threatening. The introduction of Zisavel is intended to make treatment more accessible to patients by significantly lowering costs compared to existing options such as voriconazole and posaconazole.
Who Are The Key Multinational Companies Dominating The Invasive Fungal Infections Market?
Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK PLC, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMérieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd., F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report
Which Region Currently Holds The Largest Share Of The Invasive Fungal Infections Market?
North America was the largest region in the invasive fungal infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Invasive Fungal Infections Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13189&type=smp
Browse Through More Reports Similar to the Global Invasive Fungal Infections Market 2025, By The Business Research Company
Hepatitis B Virus Hbv Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
Viral Hepatitis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report
Hepatitis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model